SCIENCE
Clinical Foundations
NEX is built on Imperial College London research, validated through peer-reviewed clinical studies, and shaped with hospital teams in real-world IPC settings.
Research-driven
Developed from Imperial College London research.
Pandemic Stress-Tested
Based on work in hospital conditions during COVID-19.
Clinically Validated
Tested and validated in hospital sites globally, published and peer reviewed.
Built with Hospital Teams
AI-powered risk intelligence to identify who's most at risk, and when to act.
CASE STUDIES
Find out more from our case studies from across the globe.
CASE 01 · RISK INTELLIGENCE
Active Targeted Surveillance
NEX predicts which patients are most likely to acquire multidrug-resistant organisms, helping IPC teams focus screening and contact tracing where risk is highest.
68%
reduction in active surveillance testing required
85%
MDRO acquisitions detected early before routine hospital screening
CASE 02 · OUTBREAK INTELLIGENCE
Improving Infection Control Compliance
NEX helped IPC teams track MDRO status, missed re-screening, and isolation workflows, supporting more consistent infection control practice across wards.
44%
increase in screening compliance within 4 months
Supporting Outcomes:
Improved isolation practice across wards
Reduced missed re-screening events
Lower avoidable ward exposure risk
CASE 03 · SURVEILLANCE INTELLIGENCE
Automating Device-Associated Infection Surveillance
NEX automates parts of device-associated infection surveillance, reducing the manual burden of case review while improving consistency and audibility.
87%
reduction in time required for case review
Supporting Outcomes:
Improved consistency in classification
Fewer cases missed through operational gaps
AI-supported audit trail for clinical safety
